Asahi Songwon
Q3 FY23 Earnings Call Analysis
Chemicals & Petrochemicals
fundraise: No informationcapex: Yesrevenue: Category 3margin: Category 3orderbook: No information
🏗️capex
Any current/future capex/capital investment/strategic investment?
- The ongoing CapEx cycle is nearing completion with only about Rs. 20 crores remaining— Rs. 10 crore at the Atlas CHATRAL Greenfield project and Rs. 10-12 crore at ATC Yellow.
- No immediate plans for new capital allocation or Greenfield expansion in the blue pigment business, aiming instead to maximize existing capacities.
- Investment of Rs. 70-75 crores in a new API site (CHATRAL plant) expected to generate Rs. 200-225 crore turnover at peak with EBITDA margins around 15%.
- The new API/intermediate site is highly efficient, with total turnover potential including internal intermediates estimated at Rs. 350-400 crore.
- The company currently does not plan forward integration in pigments for the next two years.
- Possible future capital allocation may include buybacks or investments in existing profitable business lines, subject to market conditions.
📊revenue
Future growth expectations in sales/revenue/volumes?
- Pigment business expects continued growth in the pigment selling space by increasing brand value and selling directly to big MNCs for use in inks, packaging, printing, and plastics without competing with them.
- Exposure in growing segments like plastics, packaging inks, and coatings is expanding, reducing reliance on printing (which reduced from ~70% to ~45% of sales over 5-6 years).
- Gradual recovery and bottoming out of demand anticipated with improved demand scenario expected in 2-3 months, leading to growth especially in packaging ink and plastics.
- Capacity utilization for base pigment products is currently around 55%, expected to improve to 75% in 6-8 months, enabling focus on higher-value, high-performance pigments with better margins.
- API business expects peak turnover of about Rs. 225 crores (excluding intermediates), with overall turnover including intermediates estimated at Rs. 350-400 crores eventually.
- No immediate plans for major Greenfield expansion; focus on consolidation of existing capacities and enhancing profitability.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- The company is optimistic about growth, with a recently added Greenfield facility contributing to energy and capacity expansion.
- EBITDA has reached break-even after a challenging start, indicating operational improvement.
- Increased focus on higher value-added and high-performance pigments (HPC) is expected to enhance margins and growth.
- The pigment business aims to maintain dominant market position despite competition, with plans to compete more aggressively for high-quality customers.
- API segment, including the new CHATRAL plant, targets a turnover of Rs. 200-225 crore with EBITDA margins around 15%, indicating potential earnings uplift.
- Margin improvement is seen as sustainable around 30-35%, with aspirations to reach 40-45% depending on pricing environment.
- The company anticipates a bottoming out of demand with gradual recovery starting in about 3 months, supporting future earnings growth.
- Monetization of assets like the Shiykha land parcel has improved cash flows and shareholder value.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
The transcript from the provided pages does not explicitly mention the current or expected order book or pending orders for Asahi Songwon Colors Limited. There are discussions about:
- Market demand bottoming out with a gradual pickup expected in 3 months (Page 19).
- Strong relationships with large clients and high-quality customers, focusing on customer acquisition and maintaining margins (Pages 16 and 21).
- Focus on steady growth supported by strong procurement and marketing strategies (Page 15).
- Capacity utilization levels improving, aiming to increase utilization to 75% in pigments (Page 21).
- No direct mention of the current order book or backlog of orders was available.
Therefore, there is no specific quantitative or qualitative data on order book or pending orders in the content shared.
💰fundraise
Any current/future new fundraising through debt or equity?
- As per the information on pages 8 and 9, the company has recently completed a significant CapEx cycle with about Rs. 70-75 crore invested in new API and intermediate plants.
- There are no current plans for further capital allocation toward expansion; the focus is on consolidating and maximizing utilization of existing capacities.
- The management indicated no immediate plans for new debt or equity fundraising for expansion.
- They aim to achieve returns from current investments and may consider capital allocation for profitable existing lines after 2-3 years.
- In absence of investment opportunities, surplus capital might be returned to shareholders via buybacks.
- No mention of any planned fresh fundraising through debt or equity in the near future.
